Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Millennium Pharmaceuticals, Inc.
This is a single arm Phase I study with multiple dosing cohorts as noted below: * Schedule A: MLN7243 1 mg * Schedule A: MLN7243 2 mg * Schedule A: MLN7243 4 mg * Schedule A: MLN7243 8 mg * Schedule A: MLN7243 12 mg * Schedule A: MLN7243 18 mg * Schedule A: MLN7243 Homozygous Mutant 4 mg
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted